Anaptysbio Inc (ANAB)

EBITDA Margin

54.69%

Quarterly · Period ending:

ANAB logo

ANAB EBITDA Margin

Latest reported54.69%
ANAB Quarterly EBITDA Margin (-25.44% → 54.69%)
High-resolution chart · PNG

ANAB ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anaptysbio Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
54.6857%
-122.7696%
64.6768%
50.1022%
-82.5765%
-74.2429%
-8.828%
-56.1082%
-319.9617%
-515.5871%
-379.7002%
-973.0259%
-1,008.6705%
-2,862.1543%
-316.275%
-2,071.307%
-2,147.6151%
-3,178.1443%
-3,180.3197%
-28.7075%
1.1856%
-160.3805%
56.3167%
0%
0%
-54.1467%
-664.8333%
0%
-474.34%
0%
0%
-309.34%
0%
0%
-211.9333%
0%
-31.3429%
0%
-160.0944%
-29.2782%
42.7009%
-14.7143%
-80.1184%
-13.7726%
2.7038%
-4.5887%
15.8435%
57.4586%
35.2549%
-25.4351%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.